Cytochrome C
CAS No. 9007-43-6
Cytochrome C ( —— )
Catalog No. M28900 CAS No. 9007-43-6
Cytochrome C, a protein that belongs to class 1 of the c-type cytochrome family, exerts different functions depending on its cellular localization and the conditions in which it operates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 38 | In Stock |
|
25MG | 56 | In Stock |
|
50MG | 82 | In Stock |
|
100MG | 116 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCytochrome C
-
NoteResearch use only, not for human use.
-
Brief DescriptionCytochrome C, a protein that belongs to class 1 of the c-type cytochrome family, exerts different functions depending on its cellular localization and the conditions in which it operates.
-
DescriptionCytochrome C, a protein that belongs to class 1 of the c-type cytochrome family, exerts different functions depending on its cellular localization and the conditions in which it operates.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSqualene epoxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9007-43-6
-
Formula Weight884.9
-
Molecular FormulaC42H52FeN8O6S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sawada M, et al. Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells. Eur J Pharmacol. 2001 Nov 9;431(1):11-6.
molnova catalog
related products
-
Bufotaline
Bufotaline is a kind of poisonous secretions of toads.
-
Diazolidinyl urea
Diazolidinyl urea is a formaldehyde-releasing preservative used in cosmetics and personal-care products.
-
BMS986260
BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM). BMS-986260?demonstrated functional activity in multiple TGFβ-dependent cellular assays, excellent kinome selectivity, favorable pharmacokinetic properties, and curative in vivo efficacy in combination with anti-PD-1 antibody in murine colorectal cancer (CRC) models.?